Literature DB >> 17659809

Chronobiology and chronotoxicology of antibiotics and aminoglycosides.

Denis Beauchamp1, Gaston Labrecque.   

Abstract

Few investigators have examined the circadian variation in the symptom intensity of infectious diseases. Seasonal patterns in a variety of infectious are well know. Less appreciated are the circadian patterns in the symptom expression of infections. Studies indicate that fever which accompanies the common cold peaks at 4 p.m., and this is in agreement with other studies indicating that the elevation of body temperature, fever, due to bacterial infections is higher in the evening while that due to viral infections is more likely in the morning. Animal and human studies reveal also administration-time-dependent differences in the pharmacokinetics and toxicity of antimicrobial agents. This is particularly true for the aminoglycosides, as their nephrotoxicity is greatest when administered during the resting period of laboratory animals and human beings. Food intake and low urinary pH has been found to be protective of the toxicity of aminoglycosides at this time of the day. Knowledge of the administration-time-dependence of aminoglycosides and the underlying mechanisms can be used to develop once-a-day formulations that are significantly less toxic, in particular to the kidney, in patients who require around-the-clock antimicrobial therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659809     DOI: 10.1016/j.addr.2006.07.028

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  11 in total

1.  Administration of substances to laboratory animals: routes of administration and factors to consider.

Authors:  Patricia V Turner; Thea Brabb; Cynthia Pekow; Mary Ann Vasbinder
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

Review 2.  Circadian rhythms: from basic mechanisms to the intensive care unit.

Authors:  Ming-Cheng Chan; Peter M Spieth; Kieran Quinn; Matteo Parotto; Haibo Zhang; Arthur S Slutsky
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

3.  Identifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach.

Authors:  Laura Kervezee; Jasper Stevens; Willem Birkhoff; Ingrid M C Kamerling; Theo de Boer; Melloney Dröge; Johanna H Meijer; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2015-11-25       Impact factor: 4.335

4.  Chronopharmacokinetics of once daily dosed aminoglycosides in hospitalized infectious patients.

Authors:  Erik van Maarseveen; Wai Hong Man; Johannes Proost; Cees Neef; Daniël Touw
Journal:  Int J Clin Pharm       Date:  2015-01-24

Review 5.  Circadian control of the immune system.

Authors:  Christoph Scheiermann; Yuya Kunisaki; Paul S Frenette
Journal:  Nat Rev Immunol       Date:  2013-02-08       Impact factor: 53.106

Review 6.  The significance of circadian rhythms and dysrhythmias in critical illness.

Authors:  Helen T McKenna; Irwin Km Reiss; Daniel S Martin
Journal:  J Intensive Care Soc       Date:  2017-02-13

7.  Gentamicin-induced ototoxicity and nephrotoxicity vary with circadian time of treatment and entail separate mechanisms.

Authors:  Mary A Blunston; Al Yonovitz; Erica L Woodahl; Michael H Smolensky
Journal:  Chronobiol Int       Date:  2015-10-27       Impact factor: 2.877

8.  Aminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt.

Authors:  Gamal F Gad; Heba A Mohamed; Hossam M Ashour
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

9.  Period1 mediates rhythmic metabolism of toxins by interacting with CYP2E1.

Authors:  Wenhao Ge; Tao Wang; Yang Zhao; Yunxia Yang; Qi Sun; Xiao Yang; Yan Gao; Xi Xu; Jianfa Zhang
Journal:  Cell Death Dis       Date:  2021-01-12       Impact factor: 8.469

10.  'Chronomics' in ICU: circadian aspects of immune response and therapeutic perspectives in the critically ill.

Authors:  Vasilios Papaioannou; Alexandre Mebazaa; Benoît Plaud; Matthieu Legrand
Journal:  Intensive Care Med Exp       Date:  2014-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.